RGBPRegen Biopharma, Inc.

About Regen Biopharma, Inc. (RGBP)

Regen Biopharma, Inc. (RGBP) is a Biotechnology company headquartered in La Mesa, CA, United States whose shares trade over-the-counter on the Pink tier.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.

Products and services

Human therapeutics

RGBP key facts

Ticker symbol

RGBP

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

La Mesa, CA, United States

Country of incorporation

US

Year of incorporation

2012

Employees

1

Estimated market cap

$1.38M (as of Apr 10, 2025)

Shares outstanding

21,554,704

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

9/30

Latest filing

Quarterly Report (Dec 31, 2024)

Regen Biopharma, Inc. leadership

• David Raymond Koos — CEO, CFO, President
• Joseph G. Vaini — Consultant

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with R